Co-Diagnostics, Inc.

NASDAQ:CODX

1.34 (USD) • At close September 6, 2024
Bedrijfsnaam Co-Diagnostics, Inc.
Symbool CODX
Munteenheid USD
Prijs 1.34
Beurswaarde 42,760,740
Dividendpercentage 0%
52-weken bereik 0.981 - 2.23
Industrie Medical Devices
Sector Healthcare
CEO Mr. Dwight H. Egan
Website https://www.codiagnostics.com

An error occurred while fetching data.

Over Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus,

Vergelijkbare Aandelen

Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

MIST

1.46 USD

Omeros Corporation logo

Omeros Corporation

OMER

3.64 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

0.327 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

6.13 USD

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

4.98 USD

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

RYTM

49.25 USD

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

0.952 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)